MicroRNAs as prognostic biomarkers in patients with diffuse large B-cell lymphoma

Published: 24 October 2024| Version 1 | DOI: 10.17632/f4kndmp8c5.1
Contributor:
yunfei zhao

Description

MicroRNAs as prognostic biomarkers in patients with diffuse large B-cell lymphoma,Relevant raw data and codes, etc.

Files

Steps to reproduce

The dataset generated in the current study is available in the GEO (https://www.ncbi.nlm.nih.gov/) repository under accession codes GSE173080 and GSE171272. TargetScan (https://www.targetscan.org/vert_80/), miRWalk (http://mirwalk.umm.uni-heidelberg.de/), RNA22 (https://cm.jefferson.edu/rna22/), miRTarBase (https://mirtarbase.cuhk.edu.cn/), DIANA-TarBase(http://diana.imis.athena-innovation.gr/), and NPInter(http://bigdata.ibp.ac.cn/npinter4) were used in this study. Transcribed gene expression in lymphoma patients and healthy controls is available in TCGA database (https://portal.gdc.cancer.gov/) and Genotype-Tissue Expression(GETx) database (https://xenabrowser.net), respectively. DLBCL patients with mature miRNAs and clinical data were obtained from TCGA database (https://portal.gdc.cancer.gov/).

Categories

microRNA, Exosome

Licence